Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tax-Over: Sequential Cisplatin and Docetaxel in Ovarian Cancer
NCT00772863Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2003
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in epithelial ovarian cancer (EOC), sponsored by Sanofi. Started Sep 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT00772863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772863.